SUMMARY A case of mixed acute leukaemia with T lymphoblastic, myeloblastic, and monocytic components is described. The use of immunological markers, ultrastructural morphology, cytochemistry, immunochemistry, and combined techniques, simultaneously detecting two markers in individual cells, made it possible to define the different blast cell populations. 
Neoplastic disorders are believed to arise from the uncontrolled clonal proliferation of a single progenitor cell. With the use of monoclonal antibody techniques, an increasing number of leukaemias and lymphomas' 3 are found to have a mixed phenotype. A biphenotypic leukaemia is one in which leukaemic cell populations with apparent myeloid and lymphoid characteristics coexist. This is in contrast to leukaemias of hybrid phenotype, in which leukaemic cells show phenotypic features of more than one cell line, suggesting the existence of lineage infidelity.4 This report describes a case of mixed leukaemia characterised by two distinct populations of blasts: one showed the features of acute T lymphoblastic leukaemia, the other acute myeloblastic leukaemia with some monocytic differentiation. The biphenotypic nature of this leukaemia was established by light microscopy, morphology and cytochemistry, monoclonal antibody studies, and electron microscopy.
Case report
A 65 year old woman presented with an acute leukaemia. She had a history of general malaise, recurrent infections, mouth ulcers, easy bruising, and weight loss. The salient clinical features were: fever 38°C, anaemia, bruising on the limbs, 2 cm x 1 cm tender inguinal node, palpable spleen tip, and 6 cm hepatomegaly. There was no mediastinal mass on a chest radiograph. A full blood count Accepted for publication 18 January 1985 showed haemoglobin 6*0 g/dl, white cell count 167 x 109/l (differential 98% blasts, 2% lymphocytes, with an occasional granulocyte) and platelet count 65 x 1O9/l. The biochemical profile was normal and Escherichia coli was isolated from a urine culture. A bone marrow aspirate was hypercellular with sheets of blasts, the morphological and immunological features of which are described below.
She received induction chemotherapy with daunorubicin, vincristine, and prednisolone and a bone marrow aspirate performed eight weeks later indicated complete remission. Maintenance chemotherapy was started comprising methotrexate, 6-mercaptopurine, cytosine arabinoside, vincristine, and prednisolone. The patient remains in first remission on maintenance chemotherapy 16 months after presentation.
MATERIAL AND METHODS
Light microscopy, morphology, and cytochemistry The morphology of the peripheral blood and bone marrow was examined on May-Grunwald-Giemsa stained smears. Cytochemical staining of blood and bone marrow for myeloperoxidase, Sudan Ultrastructural morphology and myeloperoxidase cytochemistry Two populations of blasts were seen by electron microscopy: lymphoid and myeloid. Fig. 1 shows a typical lymphoblast characterised by a high nuclear to cytoplasmic ratio, slightly irregular nuclear outline, peripheral chromatin condensation with some patches of heterochromatin, and a small ring form nucleolus. Nuclear pockets were noted in a significant number of cells with both lymphoid and myeloid morphology (Figs. 1 and 2 ). Lymphoblasts were uniformly unreactive for myeloperoxidase. A second population of blasts, about 20% of the cells, was myeloperoxidase positive, had typical features of myeloblasts, with a lower nuclear to cytoplasmic ratio than lymphoblasts, immature nucleus with marginal-chromatin condensation, and a small nucleolus. Short strands of endoplasmic reticulum and large to medium size granules were present in the cytoplasm of these cells. In the myeloblast illustrated in Fig. 2 the myeloperoxidase reaction is seen in the granules, in the perinuclear membrane, and in the endoplasmic reticulum. The nuclear membrane limiting the heterochromatin loops in the nuclear pocket contains myeloperoxidase and the cytoplasm enclosed by these loops also contains myeloperoxi- Fig. 3 .ilf iai.
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